|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 171.00 CZK | -2.29% |
|
+0.59% | +0.59% |
| 25/25/25 | Pilulka Lékárny a.s. Reports Earnings Results for the Full Year Ended December 31, 2024 | CI |
| 26/20/26 | Pilulka Lekarny has completed an IPO in the amount of CZK 307.41696 million. | CI |
| Capitalization | 46Cr 2.2Cr 1.89Cr 1.77Cr 1.64Cr 3.06Cr 198.72Cr 3.28Cr 20Cr 7.98Cr 95Cr 8.25Cr 8.08Cr 348.53Cr | P/E ratio 2023 |
-3.81x | P/E ratio 2024 | -2.31x |
|---|---|---|---|---|---|
| Enterprise value | 50Cr 2.38Cr 2.05Cr 1.91Cr 1.78Cr 3.31Cr 215.26Cr 3.55Cr 22Cr 8.65Cr 102.91Cr 8.93Cr 8.75Cr 377.52Cr | EV / Sales 2023 |
0.34x | EV / Sales 2024 | 0.25x |
| Free-Float |
92.21% | Yield 2023 * |
-
| Yield 2024 | - |
More valuation ratios
* Estimated data
More news
| 1 day | -2.29% | ||
| 1 week | +0.59% | ||
| Current month | +0.59% | ||
| 1 month | -3.93% | ||
| 3 months | -3.93% | ||
| 6 months | -12.31% | ||
| Current year | +0.59% |
| 1 week | 170 | 177 | |
| 1 month | 163 | 178 | |
| Current year | 163 | 177 | |
| 1 year | 90 | 315 | |
| 3 years | 80 | 775 | |
| 5 years | 80 | 1,800 | |
| 10 years | 80 | 1,800 |
| Manager | Title | Age | Since |
|---|---|---|---|
Martin Kasa
PRN | Corporate Officer/Principal | 45 | 01/01/2013 |
Petr Kasa
CEO | Chief Executive Officer | 48 | 01/01/2013 |
David Stanek
DFI | Director of Finance/CFO | - | 01/05/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Miloš Cebík
BRD | Director/Board Member | 46 | 25/06/2015 |
Martin Buchta
CHM | Chairman | 50 | 27/08/2020 |
Marek Krajcovic
BRD | Director/Board Member | 51 | 27/08/2020 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.29% | +0.59% | +83.87% | -77.94% | 2.23Cr | ||
| -2.51% | +10.41% | +139.08% | -1.95% | 2.87TCr | ||
| -7.84% | +29.19% | +114.67% | -5.53% | 1.61TCr | ||
| +1.53% | -0.68% | +20.53% | +24.70% | 650.68Cr | ||
| -1.15% | +1.79% | -6.79% | +21.59% | 490.91Cr | ||
| -1.32% | +1.44% | -7.86% | -38.76% | 396.42Cr | ||
| -1.08% | -1.55% | -23.07% | -48.40% | 321.85Cr | ||
| +0.05% | +3.48% | +32.32% | -47.90% | 306.07Cr | ||
| +0.56% | -0.19% | -8.57% | +65.33% | 289.73Cr | ||
| -0.81% | -5.45% | +37.02% | - | 190.79Cr | ||
| Average | -1.49% | +5.37% | +38.12% | -12.09% | 712.82Cr | |
| Weighted average by Cap. | -2.84% | +14.40% | +83.86% | -2.12% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 213.18Cr 10Cr 8.78Cr 8.18Cr 7.61Cr 14Cr 920.71Cr 15Cr 94Cr 37Cr 440.16Cr 38Cr 37Cr 1.61TCr | 130.42Cr 6.23Cr 5.37Cr 5Cr 4.66Cr 8.66Cr 563.28Cr 9.29Cr 58Cr 23Cr 269.29Cr 23Cr 23Cr 987.89Cr |
| Net income | -17Cr -83.62L -72.03L -67.13L -62.45L -1.16Cr -76Cr -1.25Cr -7.71Cr -3.04Cr -36Cr -3.14Cr -3.07Cr -132.51Cr | -13Cr -60.11L -51.78L -48.25L -44.89L -83.51L -54Cr -89.58L -5.54Cr -2.18Cr -26Cr -2.25Cr -2.21Cr -95Cr |
| Net Debt | 6.62Cr 31.62L 27.24L 25.39L 23.62L 43.94L 29Cr 47.13L 2.92Cr 1.15Cr 14Cr 1.19Cr 1.16Cr 50Cr | 3.83Cr 18.3L 15.76L 14.69L 13.66L 25.42L 17Cr 27.27L 1.69Cr 66.41L 7.9Cr 68.61L 67.21L 29Cr |
More financial data
* Estimated data
Employees
-
Sector
Drug Retailers
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/26/14 | 171.00 Kč | -2.29% | 1,414 |
| 13/26/13 | 175.00 Kč | -1.13% | 345 |
| 12/26/12 | 177.00 Kč | +1.14% | 611 |
| 09/26/09 | 175.00 Kč | +2.94% | 3,690 |
| 08/26/08 | 170.00 Kč | 0.00% | 863 |
End-of-day quote Prague S.E., January 14, 2026
More quotes- Stock Market
- Equities
- PINK Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















